Literature DB >> 5046120

Drug elimination and apparent volume of distribution in multicompartment systems.

M Gibaldi, D Perrier.   

Abstract

Mesh：

Substances：

Year:  1972        PMID： 5046120     DOI： 10.1002/jps.2600610630

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN： 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  16 in total

1.  Distribution, elimination and effect of furosemide in normal subjects and in patients with heart failure.

Authors:  F Andreasen; E Mikkelsen
Journal:  Eur J Clin Pharmacol       Date:  1977-08-17       Impact factor: 2.953

Review 2.  The use of pharmacokinetic principles in determining the effectiveness of removal of toxins from blood.

Authors:  W J Tilstone; J F Winchester; P C Reavey
Journal:  Clin Pharmacokinet       Date:  1979 Jan-Feb       Impact factor: 6.447

3.  Pharmacokinetic and biopharmaceutic profile of chlordiazepoxide HC1 in healthy subjects: single-dose studies by the intravenous, intramuscular, and oral routes.

Authors:  H G Boxenbaum; K A Geitner; M L Jack; W R Dixon; H E Spiegel; J Symington; R Christian; J D Moore; L Weissman; S A Kaplan
Journal:  J Pharmacokinet Biopharm       Date:  1977-02

4.  [Investigations on the penetration of cefamandole into spinal fluid (author's transl)].

Authors:  B Oellers; O Müller; K Fabricius; J Ungemach
Journal:  Infection       Date:  1978       Impact factor: 3.553

5.  [Serum concentrations and kinetics after intravenous infusion of four grams of cefazolin (author's transl)].

Authors:  D Adam; J Pätzold
Journal:  Infection       Date:  1977       Impact factor: 3.553

6.  Pitfalls of pharmacokinetic dosage guidelines in renal insufficiency.

Authors:  K Turnheim
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

7.  [Pharmacokinetics of azlocillin, a new semisynthetic, wide-spectrum antibiotic (author's transl)].

Authors:  K Wirth; M Schomerus; J H Hengstmann
Journal:  Infection       Date:  1976       Impact factor: 3.553

Review 8.  Drug dosage in renal disease.

Authors:  L Dettli
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

9.  The pharmacokinetics of furazlocillin in healthy humans.

Authors:  P H Hinderling; U Gundert-Remy; D Förster; W Gau
Journal:  J Pharmacokinet Biopharm       Date:  1983-02

10.  Pharmacokinetics of metioprim in normal subjects and patients with impaired renal function.

Authors:  H Vergin; G B Bishop-Freudling; W Kaiser; M Köhler; K Strobel; F W Reutter
Journal:  Antimicrob Agents Chemother       Date:  1983-08       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.